🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Cisplatin or Carboplatin will be given on day 1 every 21 days for 6 cycles;...
Status
Completed
Location
Princess Margaret Hospital
Start Date
2006-06
Trial ID
NCT00603915
Treatments Being Tested
The main goals are after treatment given before surgery, to measure the num...
Status
Recruiting
Location
Southern Cancer Center (SCC) ( Site 8004)
Start Date
2025-03-20
Trial ID
NCT06788912
This is a prospective single arm, multi-center, phase II clinical trial to ...
Status
Suspended
Location
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
Start Date
2020-12-25
Trial ID
NCT04668365
Treatments Being Tested
The study is being conducted to evaluate the efficacy of SHR-A2102 with ade...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-02-12
Trial ID
NCT07393542
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Withdrawn
Location
St. Joseph's Hospital and Medical Center
Start Date
2002-11
Trial ID
NCT00055887
This study is designed to explore the potential of the epigenetic agent RRx...
Status
Completed
Location
Stanford University
Start Date
2015-06
Trial ID
NCT02489903
A prospective, single-arm, non-randomized, multi-center, open-label study f...
Status
Terminated
Location
Mayo Clinic Rochester
Start Date
2023-02-01
Trial ID
NCT05583188
The present study is a randomized, blinded, placebo-controlled, two-Phase, ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06
Trial ID
NCT01147809
Treatments Being Tested
The objective of this study is to evaluate the efficacy and safety of sacit...
Status
Recruiting
Location
The University of Arizona Cancer Center-North Campus
Start Date
2018-08-13
Trial ID
NCT03547973
This phase II trial studies the effect of avelumab, gemcitabine and carbopl...
Status
Terminated
Location
University of Colorado Hospital
Start Date
2022-08-10
Trial ID
NCT04871529
Treatments Being Tested